| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 7.67M | — |
| Operating expense | — | — |
| Net income | -4.78M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, RJR1.F returned -50.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -37.8% |
| 1 year | -50.5% |
| 5 years | -77.6% |
| 10 years | +77.0% |
| All-time high | €112.10 (Feb 2006) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in RJR1.F would be worth today ›No. Stereotaxis, Inc. has not paid a dividend in the past 12 months.
Stereotaxis, Inc. is part of the Healthcare sector.
Stereotaxis, Inc. has a market cap of 119.04M EUR, based on the latest quote.
Stereotaxis, Inc. is scheduled to report earnings on Nov 16, 2026.
